Aspirin improves the patency rate of seeded vena cava grafts.
The purpose of this study was to evaluate the effectiveness of aspirin (ASA) and porcine endothelial cell seeding in improving the patency rate of vena cava grafts. Thirty-nine dogs underwent infrarenal vena cava replacement by 10 cm lengths of 8 mm I.D. ringed polytetrafluoroethylene grafts. Thirty-one grafts were seeded with 1-1.5 x 10(6) porcine aortic endothelial cells while eight were not (GIII). Of the seeded group, 16 animals received no ASA (GI), while 15 others (GII) were given ASA (325 mg) daily starting two days preoperatively and continuing until sacrifice. Venograms were performed on the fourth postoperative day. Grafts were harvested 32 days after insertion and evaluated for patency rate and endothelialized surfaces. The 32-day patency rate was significantly higher for GII than for GI and III animals (67% vs. 13 and 25% respectively). Endothelialized surface was higher in GII than Gi and III (67% vs. 16% and 18% respectively). We conclude that endothelial cell seeding alone does not prevent graft closure and that a combination of ASA and cell seeding significantly increases the patency rate of vena cava grafts.
Vo
N M
NM
Department of Surgery, East Tennessee State University, Johnson City.
Arbogast
L Y
LY
Friedlander
E
E
Stanton
P E
PE
Arbogast
B
B
D000818:Animals; D001241:Aspirin / Q000494:pharmacology*; D001807:Blood Vessel Prosthesis; D004285:Dogs; D004730:Endothelium, Vascular / Q000166:cytology; D006083:Graft Occlusion, Vascular; D006801:Humans; D010974:Platelet Aggregation / Q000187:drug effects; D013552:Swine; D014654:Vascular Patency; D014684:Venae Cavae / Q000601:surgery*
D001241:Aspirin